UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cytomegalovirus in Solid Organ Transplantation

American journal of transplantation, 2013-03, Vol.13 (s4), p.93-106

2013

Volltextzugriff (PDF)

An Interventional Study Using Cell‐Mediated Immunity to Personalize Therapy for Cytomegalovirus Infection After Transplantation

American journal of transplantation, 2017-09, Vol.17 (9), p.2468-2473

2017

Volltextzugriff (PDF)

Cytomegalovirus in Solid Organ Transplant Recipients

American journal of transplantation, 2009-12, Vol.9, p.S78-S86

2009

Volltextzugriff (PDF)

CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia

Blood, 2013-08, Vol.122 (7), p.1316-1324

2013

Volltextzugriff (PDF)

International consensus guidelines on the management of cytomegalovirus in solid organ transplantation

Transplantation, 2010-04, Vol.89 (7), p.779-795

2010

Volltextzugriff (PDF)

The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High‐Risk Kidney Transplant Recipients

American journal of transplantation, 2010-05, Vol.10 (5), p.1228-1237

2010

Volltextzugriff (PDF)

Cytomegalovirus mismatch still negatively affects patient and graft survival in the era of routine prophylactic and preemptive therapy: A paired kidney analysis

American journal of transplantation, 2019-02, Vol.19 (2), p.573-584

2019

Volltextzugriff (PDF)

Cytomegalovirus Infection in Pediatric Renal Transplantation and the Impact of Chemoprophylaxis With (Val-)Ganciclovir

Transplantation, 2016-04, Vol.100 (4), p.862-870

2016

Volltextzugriff (PDF)

Letermovir prophylaxis reduced cytomegalovirus reactivation and resistance post umbilical cord blood transplantation

British journal of haematology, 2024-06, Vol.204 (6), p.2378-2389

2024

Volltextzugriff (PDF)

Cytomegalovirus breakthrough and resistance during letermovir prophylaxis

Bone marrow transplantation (Basingstoke), 2023-04, Vol.58 (4), p.430-436

2023

Volltextzugriff (PDF)

Antiviral Agents for Preventing Cytomegalovirus Disease in Recipients of Hematopoietic Cell Transplantation

Viruses, 2024-08, Vol.16 (8), p.1268

2024

Volltextzugriff (PDF)

Cytomegalovirus transmission in mismatched solid organ transplant recipients: Are factors other than anti‐viral prophylaxis at play?

American journal of transplantation, 2021-12, Vol.21 (12), p.3958-3970

2021

Volltextzugriff (PDF)

New Developments in the Management of Cytomegalovirus Infection after Solid Organ Transplantation

Drugs (New York, N.Y.), 2010-05, Vol.70 (8), p.965-981

2010

Volltextzugriff (PDF)

CMV Immunoglobulins for the Treatment of CMV Infections in Thoracic Transplant Recipients

Transplantation, 2016-03, Vol.100 Suppl 3 (Supplement 3S), p.S5-S10

2016

Volltextzugriff (PDF)

The Association Between Cytomegalovirus Infection and Cardiac Allograft Vasculopathy in the Era of Antiviral Valganciclovir Prophylaxis

Transplantation, 2020-07, Vol.104 (7), p.1508-1518

2020

Volltextzugriff (PDF)

Effect of CMV Mismatch on Heart Transplant Outcomes Using a Surveillance and Preemptive Strategy

Clinical transplantation, 2024-09, Vol.38 (9), p.e15419-n/a

2024

Volltextzugriff (PDF)

Cytomegalovirus Post‐Prophylaxis Surveillance in High‐Risk Kidney and Liver Recipients Prevents CMV End‐Organ Disease and Ganciclovir‐Resistance

Clinical transplantation, 2024-09, Vol.38 (9), p.e15453-n/a

2024

Volltextzugriff (PDF)

Cytomegalovirus prevention strategies and the risk of BK polyomavirus viremia and nephropathy

American journal of transplantation, 2019-09, Vol.19 (9), p.2457-2467

2019

Volltextzugriff (PDF)

The Influence of Antithymocyte Globulin Dose on the Incidence of CMV Infection in High-risk Kidney Transplant Recipients Without Pharmacological Prophylaxis

Transplantation, 2020-10, Vol.104 (10), p.2139-2147

2020

Volltextzugriff (PDF)

Risk factor analysis for cytomegalovirus reactivation under prophylaxis with letermovir after allogeneic hematopoietic stem cell transplantation

Transplant infectious disease, 2022-12, Vol.24 (6), p.e13904-n/a

2022

Volltextzugriff (PDF)

Evaluation of Low- Versus High-dose Valganciclovir for Prevention of Cytomegalovirus Disease in High-risk Renal Transplant Recipients

Transplantation, 2015-07, Vol.99 (7), p.1499-1505

2015

Volltextzugriff (PDF)

Delayed-Onset Primary Cytomegalovirus Disease and the Risk of Allograft Failure and Mortality after Kidney Transplantation

Clinical infectious diseases, 2008-03, Vol.46 (6), p.840-846

2008

Volltextzugriff (PDF)

Real‐life use of letermovir prophylaxis for cytomegalovirus in heart transplant recipients

Clinical transplantation, 2024-05, Vol.38 (5), p.e15327-n/a

2024

Volltextzugriff (PDF)

Pre-Transplant Frequencies of FoxP3 + CD25 + in CD3 + CD8 + T Cells as Potential Predictors for CMV in CMV-Intermediate Risk Kidney Transplant Recipients

Transplant international, 2024-05, Vol.37, p.12963

2024

Volltextzugriff (PDF)

Evolving trends in immunosuppression use and cytomegalovirus infection risk over the past decade in kidney transplantation

Transplant infectious disease, 2024-10, Vol.26 (5), p.e14318-n/a

2024

Volltextzugriff (PDF)

1 – 25 von 328

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieTransplantation Proceedings

ThemaRisk Factors

ThemaTransplantation

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(307)
Mit Volltextzugriff
(258)

Publikationsform

Artikel
(328)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(323)
Science & Technology
(321)
Life Sciences & Biomedicine
(318)
Cytomegalovirus Infections - Prevention & Control
(243)
Female
(232)
Cytomegalovirus
(229)
Male
(227)
Middle Aged
(201)
Adult
(199)
Immunology
(173)
Antiviral Agents - Therapeutic Use
(141)
Biological And Medical Sciences
(134)
Medical Sciences
(134)
Retrospective Studies
(121)
Surgery
(119)
Adolescent
(102)
Infectious Diseases
(92)
Hematology
(90)

13 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Cytomegalovirus in Solid Organ Transplantation

An Interventional Study Using Cell‐Mediated Immunity to Personalize Therapy for Cytomegalovirus Infection After Transplantation

Cytomegalovirus in Solid Organ Transplant Recipients

CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia

International consensus guidelines on the management of cytomegalovirus in solid organ transplantation

The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High‐Risk Kidney Transplant Recipients

Cytomegalovirus mismatch still negatively affects patient and graft survival in the era of routine prophylactic and preemptive therapy: A paired kidney analysis

Cytomegalovirus Infection in Pediatric Renal Transplantation and the Impact of Chemoprophylaxis With (Val-)Ganciclovir

Letermovir prophylaxis reduced cytomegalovirus reactivation and resistance post umbilical cord blood transplantation

Cytomegalovirus breakthrough and resistance during letermovir prophylaxis

Antiviral Agents for Preventing Cytomegalovirus Disease in Recipients of Hematopoietic Cell Transplantation

Cytomegalovirus transmission in mismatched solid organ transplant recipients: Are factors other than anti‐viral prophylaxis at play?

New Developments in the Management of Cytomegalovirus Infection after Solid Organ Transplantation

CMV Immunoglobulins for the Treatment of CMV Infections in Thoracic Transplant Recipients

The Association Between Cytomegalovirus Infection and Cardiac Allograft Vasculopathy in the Era of Antiviral Valganciclovir Prophylaxis

Effect of CMV Mismatch on Heart Transplant Outcomes Using a Surveillance and Preemptive Strategy

Cytomegalovirus Post‐Prophylaxis Surveillance in High‐Risk Kidney and Liver Recipients Prevents CMV End‐Organ Disease and Ganciclovir‐Resistance

Cytomegalovirus prevention strategies and the risk of BK polyomavirus viremia and nephropathy

The Influence of Antithymocyte Globulin Dose on the Incidence of CMV Infection in High-risk Kidney Transplant Recipients Without Pharmacological Prophylaxis

Risk factor analysis for cytomegalovirus reactivation under prophylaxis with letermovir after allogeneic hematopoietic stem cell transplantation

Evaluation of Low- Versus High-dose Valganciclovir for Prevention of Cytomegalovirus Disease in High-risk Renal Transplant Recipients

Delayed-Onset Primary Cytomegalovirus Disease and the Risk of Allograft Failure and Mortality after Kidney Transplantation

Real‐life use of letermovir prophylaxis for cytomegalovirus in heart transplant recipients

Pre-Transplant Frequencies of FoxP3 + CD25 + in CD3 + CD8 + T Cells as Potential Predictors for CMV in CMV-Intermediate Risk Kidney Transplant Recipients

Evolving trends in immunosuppression use and cytomegalovirus infection risk over the past decade in kidney transplantation

Aktive Filter

Suchergebnisse filtern